These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 11543655)

  • 1. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
    Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
    Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments.
    Burioni R; Plaisant P; Manzin A; Rosa D; Delli Carri V; Bugli F; Solforosi L; Abrignani S; Varaldo PE; Fadda G; Clementi M
    Hepatology; 1998 Sep; 28(3):810-4. PubMed ID: 9731577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human antibodies from phage display libraries: expression of recombinant full length immunoglobulin G specific to the hepatitis C virus E2 glycoprotein.
    Bugli F; Graffeo R; Pescatori M; Paroni Sterbini F; Torelli R; Masucci L; Manzara S; Fadda G
    New Microbiol; 2009 Oct; 32(4):341-9. PubMed ID: 20128440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity.
    Schofield DJ; Bartosch B; Shimizu YK; Allander T; Alter HJ; Emerson SU; Cosset FL; Purcell RH
    Hepatology; 2005 Nov; 42(5):1055-62. PubMed ID: 16250048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses.
    Goncalvez AP; Men R; Wernly C; Purcell RH; Lai CJ
    J Virol; 2004 Dec; 78(23):12910-8. PubMed ID: 15542643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.
    Mancini N; Canducci F; Carletti S; Berardinelli E; Serafini G; Grieco A; Perotti M; Malcangi G; Danieli MG; Varaldo PE; Clementi M; Burioni R
    J Biol Regul Homeost Agents; 2003; 17(2):183-7. PubMed ID: 14518720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.
    Burioni R; Mancini N; Carletti S; Perotti M; Grieco A; Canducci F; Varaldo PE; Clementi M
    Virology; 2004 Oct; 327(2):242-8. PubMed ID: 15351212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabs specific for 8-oxoguanine: control of DNA binding.
    Bespalov IA; Bond JP; Purmal AA; Wallace SS; Melamede RJ
    J Mol Biol; 1999 Nov; 293(5):1085-95. PubMed ID: 10547287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library.
    Mink MA; Benichou S; Madaule P; Tiollais P; Prince AM; Inchauspe G
    Virology; 1994 Apr; 200(1):246-55. PubMed ID: 7510436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization.
    Zucchelli S; Roccasecca R; Meola A; Ercole BB; Tafi R; Dubuisson J; Galfré G; Cortese R; Nicosia A
    Hepatology; 2001 Mar; 33(3):692-703. PubMed ID: 11230750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation of human single chain Fv antibody specifically against hepatitis C virus E2 antigen].
    Zhong Y; Cheng J; Shi S; Wang G; Xia X; Tian X; Li L; Zhang L; Chen J
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):109-11. PubMed ID: 11983126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internal images: human anti-idiotypic Fab antibodies mimic the IgE epitopes of grass pollen allergen Phl p 5a.
    Hantusch B; Knittelfelder R; Wallmann J; Krieger S; Szalai K; Untersmayr E; Vogel M; Stadler BM; Scheiner O; Boltz-Nitulescu G; Jensen-Jarolim E
    Mol Immunol; 2006 Jul; 43(14):2180-7. PubMed ID: 16510185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of an HFRS patient-derived neutralizing recombinant antibody to Hantaan virus G1 protein and definition of the neutralizing domain.
    Liang M; Mahler M; Koch J; Ji Y; Li D; Schmaljohn C; Bautz EK
    J Med Virol; 2003 Jan; 69(1):99-107. PubMed ID: 12436484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein.
    Diotti RA; Sautto GA; Solforosi L; Mancini N; Clementi M; Burioni R
    New Microbiol; 2012 Oct; 35(4):475-9. PubMed ID: 23109015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries.
    Bugli F; Mancini N; Kang CY; Di Campli C; Grieco A; Manzin A; Gabrielli A; Gasbarrini A; Fadda G; Varaldo PE; Clementi M; Burioni R
    J Virol; 2001 Oct; 75(20):9986-90. PubMed ID: 11559832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
    Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
    J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antibody affinity to Japanese encephalitis virus E protein by phage display.
    Hong WW; Yen YH; Wu SC
    Biochem Biophys Res Commun; 2007 Apr; 356(1):124-8. PubMed ID: 17350601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
    Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
    Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-germ-line encoded residues are critical for effective antibody recognition of a poorly immunogenic neutralization epitope on glycoprotein B of human cytomegalovirus.
    Lantto J; Lindroth Y; Ohlin M
    Eur J Immunol; 2002 Jun; 32(6):1659-69. PubMed ID: 12115649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of therapeutic human monoclonal antibodies for varicella-zoster virus and the effect of light chains on the neutralizing activity.
    Suzuki K; Akahori Y; Asano Y; Kurosawa Y; Shiraki K
    J Med Virol; 2007 Jun; 79(6):852-62. PubMed ID: 17457901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.